Both in Biotechnology
Lexeo Therapeutics vs ProKidney
Over the past year LXEO returned −65.6% and PROK returned −62.5%; their daily moves had a correlation of 0.32.
LXEO −65.6% PROK −62.5%Growth of $1, one year, split-adjusted
| Metric | LXEO | PROK |
|---|---|---|
| Price | $3.11 | $1.07 |
| Market cap | $255.3M | $223.6M |
| Today | +1.63% | −4.46% |
| 1 month | −8.8% | −32.3% |
| 6 months | −47.8% | −44.3% |
| Year to date | −68.7% | −52.2% |
| 1 year | −68.9% | −65.0% |
| Revenue growth (YoY) | — | −32.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −18948.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 273.4× |
| Net cash | $211.1M | $181.6M |
| Dividend yield | — | — |
| Volatility (60d) | 69.1% | 85.3% |
| Short % of float | 22.9% | 27.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).